Search results for "hepatic"

showing 10 items of 609 documents

CIAS detection of Fasciola hepatica/F. gigantica intermediate forms in bovines from Bangladesh

2015

Fascioliasis is an important food-borne parasitic zoonosis caused by two trematode species, Fasciola hepatica and Fasciola gigantica. The characterisation and differentiation of Fasciola populations is crucial to control the disease, given the different transmission, epidemiology and pathology characteristics of the two species. Lineal biometric features of adult liver flukes infecting livestock have been studied to characterise and discriminate fasciolids from Bangladesh. An accurate analysis was conducted to phenotypically discriminate between fasciolids from naturally infected bovines (cattle, buffaloes) throughout the country. Morphometric analyses were made with a computer image analys…

0301 basic medicineFascioliasisVeterinary medicineBiometryFasciola gigantica030231 tropical medicineCattle DiseasesCattle Diseases03 medical and health sciences0302 clinical medicineHepaticaparasitic diseasesmedicineAnimalsFasciola hepaticaBangladeshbiologyFasciolabusiness.industryZoonosis030108 mycology & parasitologybiology.organism_classificationmedicine.diseaseFasciolaMalalties parasitàriesParasitologyCattleParasitologyLivestockbusinessBestiar boví
researchProduct

Epidemiology of fascioliasis in human endemic areas

2005

AbstractConsidered a secondary zoonotic disease until the mid-1990s, human fascioliasis is at present emerging or re-emerging in many countries, including increases of prevalence and intensity and geographical expansion. Research in recent years has justified the inclusion of fascioliasis in the list of important human parasitic diseases. At present, fascioliasis is a vector-borne disease presenting the widest known latitudinal, longitudinal and altitudinal distribution.Fasciola hepaticahas succeeded in expanding from its European original geographical area to colonize five continents, despite theoretical restrictions related to its biology and in turn dependent upon environmental and human…

0301 basic medicineFascioliasismedicine.medical_specialtyEndemic DiseasesRange (biology)030231 tropical medicineHelminthiasisDistribution (economics)DiseaseBiologyZoonotic diseaseDisease Outbreaks03 medical and health sciences0302 clinical medicineEnvironmental healthEpidemiologyPrevalencemedicineAnimalsHumansChildbusiness.industryTransmission (medicine)AltitudeGeneral MedicineFasciola hepatica030108 mycology & parasitologymedicine.diseaseFasciolaHuman fascioliasisFemaleAnimal Science and ZoologyParasitologybusinessJournal of Helminthology
researchProduct

Diversity of extracellular vesicles from different developmental stages of Fasciola hepatica

2020

The secretion of extracellular vesicles (EVs) in Fasciola hepatica adult worms was described by our group in 2012. Since then, EVs have been found in other helminths, thus providing a new paradigm for the complete understanding of host-parasite communication. However, information was lacking regarding the possible existence and role of EVs from other developmental stages of the parasite. In this study, we confirm the secretion of EVs by F. hepatica eggs and juvenile forms. EVs were isolated by size exclusion chromatography and characterised by nanoparticle tracking analysis and electron microscopy. We observed a large diversity in the morphologies of these EVs, suggesting specific functions…

0301 basic medicineFuture studies030231 tropical medicineNanoparticle tracking analysisExtracellular vesicles03 medical and health sciencesExtracellular Vesicles0302 clinical medicineHepaticaSize exclusion chromatographyparasitic diseasesFasciola hepaticaParasite hostingAnimalsSecretionLife Cycle StagesbiologyVesicleFasciola hepaticaExtracellular vesiclesbiology.organism_classificationCell biology030104 developmental biologyInfectious DiseasesFasciola hepatica juvenilesParasitology
researchProduct

Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.

2021

BACKGROUND & AIMS: Fatty liver disease (FLD) is a growing epidemic that is expected to be the leading cause of end-stage liver disease within the next decade. Both environmental and genetic factors contribute to the susceptibility of FLD. Several genetic variants contributing to FLD have been identified in exome-wide association studies. However, there is still a missing hereditability indicating that other genetic variants are yet to be discovered. METHODS: To find genes involved in FLD, we first examined the association of missense and nonsense variants with alanine amino transferase at an exome-wide level in 425,671 participants from the UK Biobank. We then validated genetic variants wit…

0301 basic medicineGenome-wide association studyLiver disease0302 clinical medicineENRICHMENT ANALYSISNon-alcoholic Fatty Liver DiseaseRisk FactorsNonalcoholic fatty liver diseaseExomeCONFERS SUSCEPTIBILITYGeneticsINSULIN-RESISTANCEmedicine.diagnostic_testFatty liverGastroenterologyAlanine Transaminase1-Acylglycerol-3-Phosphate O-Acyltransferase3. Good healthGENOMEEuropePhenotypeLiver biopsy030211 gastroenterology & hepatologyNonalcoholic Fatty Liver DiseaseMAFLDSingle-nucleotide polymorphismBiologyTransaminaseRisk Assessment03 medical and health sciencesApolipoproteins ENAFLDmedicineGenetic predispositionHumansGenetic Predisposition to DiseaseHEPATIC STEATOSISGenetic associationMAFLD Phenotype Reproducibility of Results Risk Assessment Risk Factors Transcriptome Genetic Variation Metabolic Associated Fatty Liver Disease Nonalcoholic Fatty Liver Disease Transaminase 1-Acylglycerol-3-Phosphate O-Acyltransferase Alanine Transaminase Apolipoproteins E Biomarkers Europe Exome Gene Expression Profiling Genetic Predisposition to Disease Genome-Wide Association Study Humans Non-alcoholic Fatty Liver DiseaseHepatologyMUTATIONSGene Expression ProfilingGenetic VariationReproducibility of Resultsmedicine.diseaseX-RECEPTORGENE030104 developmental biology3121 General medicine internal medicine and other clinical medicineMetabolic Associated Fatty Liver DiseaseRNA-SEQ DATATranscriptomePATHOGENICITYBiomarkersGenome-Wide Association StudyGastroenterology
researchProduct

Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation

2016

While the role of both elevated levels of circulating bacterial cell wall components and adipose tissue in hepatic fat accumulation has been recognized, it has not been considered that the bacterial components-recognizing adipose tissue receptors contribute to the hepatic fat content. In this study we found that the expression of adipose tissue bacterial flagellin (FLG)-recognizing Toll-like receptor (TLR) 5 associated with liver fat content (r = 0.699, p = 0.003) and insulin sensitivity (r = -0.529, p = 0.016) in humans (n = 23). No such associations were found for lipopolysaccharides (LPS)-recognizing TLR4. To study the underlying molecular mechanisms of these associations, human HepG2 he…

0301 basic medicineGlycerollcsh:MedicineAdipose tissueWhite adipose tissueflagellinBiochemistryImmune ReceptorsFatsEndocrinologyAnimal CellsAdipocytesMedicine and Health SciencesInsulinlcsh:ScienceToll-like ReceptorsConnective Tissue CellsMultidisciplinaryImmune System ProteinsbiologyLiver DiseasesFatty liverin kaltaiset reseptorit [toll]Lipidsadipose tissuePhysical sciencesChemistryMitochondrial respiratory chainAdipose TissueConnective Tissuebacterial componentsCellular TypesAnatomyinsuline sensitivityResearch ArticleSignal Transductionmedicine.medical_specialtyadipocytesImmunologyMonomers (Chemistry)Gastroenterology and Hepatologyta311103 medical and health sciencesInsulin resistanceInternal medicinemedicinePolymer chemistryDiabetic Endocrinologylcsh:Rta1183ta1182Biology and Life SciencesProteinsCell Biologyliver fatmedicine.diseasehepatic fatfat accumulationHormonesIRS1Fatty LiverInsulin receptor030104 developmental biologyEndocrinologyBiological TissueTLR5biology.proteinlcsh:QPLoS ONE
researchProduct

Between reality and the guidelines: A survey on perception, diagnosis and management of hepatic encephalopathy in 201 Italian specialist centres

2017

0301 basic medicineHealth Knowledge Attitudes Practicemedicine.medical_specialtyAttitude of Health Personnelmedia_common.quotation_subjectHepatology; Gastroenterology03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPerceptionInternal medicinemedicineHumansPractice Patterns Physicians'Hepatic encephalopathymedia_commonAcademic Medical CentersHepatologybusiness.industryGastroenterologyHepatologymedicine.diseaseHospitals030104 developmental biologyItalyHepatic EncephalopathyFamily medicinePractice Guidelines as Topic030211 gastroenterology & hepatologyGuideline Adherencebusiness
researchProduct

Effects of 3,5-diiodo-L-thyronine on the liver of high fat diet fed rats

2016

Experimental studies have highlighted that the administration of 3,5-diiodo-L-thyronine (T2) to rats fed diets rich in lipids induces a decrease of cholesterol and triglycerides plasma levels and body weight (BW) without inducing liver steatosis. On the basis of these observations we carried out some experimental <em>in vivo</em> studies to assess the effects of multiple high doses of T2 on the pituitary thyroid axis of rats fed diet rich in lipids. Fifteen male Wistar rats were divided into three groups of five animals each. The first group (N group) received standard diet, the second group was fed with a high fat diet (HFD group), while the third group (HFDT2 group) was additi…

0301 basic medicineHepatic steatosismedicine.medical_specialtyPlant ScienceAdrenocorticotropic hormoneHepatic steatosi010501 environmental sciencesBiologySettore BIO/09 - Fisiologia01 natural sciencesGeneral Biochemistry Genetics and Molecular BiologyPituitary thyroid axis03 medical and health scienceschemistry.chemical_compoundInternal medicinemedicinelcsh:QH301-705.50105 earth and related environmental sciences35-diiodo-L-thyronine; TSH; Thyroid hormone; Hepatic steatosisBiochemistry Genetics and Molecular Biology (all)TriiodothyronineTSHCholesterolBiochemistry (medical)medicine.diseaseSettore CHIM/08 - Chimica Farmaceutica35-diiodo-L-thyronineThyroid hormone030104 developmental biologyEndocrinologylcsh:Biology (General)chemistryThyronineSettore BIO/14 - FarmacologiaAlkaline phosphataseSteatosisHormoneJournal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
researchProduct

DNA multigene characterization of Fasciola hepatica and Lymnaea neotropica and its fascioliasis transmission capacity in Uruguay, with historical cor…

2017

Background Fascioliasis is a pathogenic disease transmitted by lymnaeid snails and recently emerging in humans, in part due to effects of climate changes, anthropogenic environment modifications, import/export and movements of livestock. South America is the continent presenting more human fascioliasis hyperendemic areas and the highest prevalences and intensities known. These scenarios appear mainly linked to altitude areas in Andean countries, whereas lowland areas of non-Andean countries, such as Uruguay, only show sporadic human cases or outbreaks. A study including DNA marker sequencing of fasciolids and lymnaeids, an experimental study of the life cycle in Uruguay, and a review of hum…

0301 basic medicineHeredityPhysiologySnailsHelminth geneticsMoltingGeographical locationslaw.invention0302 clinical medicinelawRNA Ribosomal 16SMedicine and Health SciencesCluster AnalysisPhylogenyGalba truncatulaMammalsbiologyEcologylcsh:Public aspects of medicineAgricultureRuminants030108 mycology & parasitologyDNA HelminthGenetic MappingInfectious DiseasesTransmission (mechanics)Helminth InfectionsVertebratesResearch ArticleNeglected Tropical DiseasesMitochondrial DNAFascioliasisLivestocklcsh:Arctic medicine. Tropical medicineGenotypelcsh:RC955-962030231 tropical medicineDNA RibosomalRisk Assessment03 medical and health sciencesHepaticaBovinesAcanthaceaeDNA Ribosomal Spacerparasitic diseasesGeneticsParasitic DiseasesFasciola hepaticaAnimalsHumansHorsesSheepPublic Health Environmental and Occupational HealthOrganismsOutbreakGenetic VariationBiology and Life Scienceslcsh:RA1-1270Sequence Analysis DNAMolluscsParasitologia veterinàriaFasciola hepaticaSouth Americabiology.organism_classificationTropical DiseasesInvertebratesHaplotypesGastropodsVector (epidemiology)AmniotesUruguayCattlePeople and placesBestiarPhysiological ProcessesPLoS Neglected Tropical Diseases
researchProduct

Does iris(in) bring bad news or good news?

2017

Irisin, a novel myokine produced in response to physical activity, promotes white-to-brown fat transdifferentiation. The name irisin referred to the ancient Greek goddess Iris, the messenger who delivered (bad) news from the gods. In mice, it has been demonstrated that irisin plays a key role in metabolic regulation, energy expenditure and glucose homeostasis. New findings from various studies carried out in both animals and humans suggest that irisin might also have other favorable effects, such as increasing bone cortical mass, preventing hepatic lipid accumulation, and improving cognitive functions, thus mediating many exercise-induced health benefits. However, data on the role and funct…

0301 basic medicineIrisinmedicine.medical_specialtyPhysical activitySkeletal muscle030209 endocrinology & metabolismHealth benefitsBioinformaticsType 2 diabeteSettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineMyokineInternal medicineMyokinemedicineAnimalsHomeostasisHumansGlucose homeostasisLack of knowledgeObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateMuscle SkeletalExercisebusiness.industryFibronectinsPsychiatry and Mental healthClinical PsychologyGlucose030104 developmental biologyEndocrinologyAdipose TissueEnergy expenditureMetabolic regulationHepatic lipidAdipose tissue browningEnergy MetabolismbusinessEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
researchProduct

Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites

2017

Advances in organ-on-chip technologies for the application in in vitro drug development provide an attractive alternative approach to replace ethically controversial animal testing and to establish a basis for accelerated drug development. In recent years, various chip-based tissue culture systems have been developed, which are mostly optimized for cultivation of one single cell type or organoid structure and lack the representation of multi organ interactions. Here we present an optimized microfluidic chip design consisting of interconnected compartments, which provides the possibility to mimic the exchange between different organ specific cell types and enables to study interdependent cel…

0301 basic medicineKidneyCell typeBiomedical Engineering02 engineering and technologyComputational biologyBiology021001 nanoscience & nanotechnologyBiomaterials03 medical and health sciencesTissue culture030104 developmental biologymedicine.anatomical_structureDrug developmentToxicityHepatic stellate cellOrganoidmedicine0210 nano-technologyDrug metabolismBiomedical engineeringACS Biomaterials Science & Engineering
researchProduct